neuropathy

Rethinking topical relief for diabetic nerve pain

Amc Ting

One of the many ways that diabetes alters the lives of people is the onset of neuropathic pain. A problem that is often seen as a minor side effect, for which the relief comes down to the ineffective choice between oral medication or topical creams. Both of these only address the symptom, having no effect on the core issue of the nerve tissues being worn down by prolonged glucose stress. However, as research into diabetes deepens, a different class of topical therapy is being developed that tackles the nerve stress and restores the conditions it needs to function.

How AMPK activation calms glucose-stressed nerves

The biological consequences of diabetes are determined by the metabolic dysfunction it initiates within cells. In peripheral nerves, chronic hyperglycaemia disrupts the systems that govern cellular energy homeostasis, undermining the metabolic capacity required to sustain neuronal function and repair. As energy availability declines, nerve tissue progressively loses its ability to function normally, giving rise to the burning, tingling, numbness, and sensory deterioration associated with diabetic peripheral neuropathy.

At the centre of cellular energy regulation is AMP-activated protein kinase (AMPK), the body's master metabolic regulator. Activated in response to energy stress, AMPK restores metabolic homeostasis by enhancing glucose uptake, improving lipid metabolism, supporting mitochondrial function, and attenuating the oxidative stress that drives progressive neuronal injury.

Nuroformin is engineered around this biological pathway. Rather than simply addressing the symptoms of neuropathy, it targets the metabolic dysfunction that precedes nerve degeneration by activating AMPK directly within peripheral nerve tissue. By restoring cellular energy homeostasis where neuronal damage begins, it supports the physiological processes essential for long-term nerve function and recovery.

Where the skin barrier and nerve fibre converge

Diabetic peripheral neuropathy is often viewed as a disorder of the nerves alone. In reality, its biology extends beyond the nerve fibre itself. The terminal endings of sensory neurons reside within the skin, making epidermal health an essential part of the neural environment. Hydration, barrier function and local circulation shape the conditions under which nerves function, respond to stress and recover from injury.

Diabetes progressively weakens this relationship. Reduced hydration, impaired collagen renewal and diminished microvascular perfusion compromise the skin's protective capacity while limiting the delivery of oxygen and nutrients to the tissues beneath. As the nerve function declines, normal skin renewal also deteriorates, creating a cycle in which both tissues become increasingly vulnerable.

Nuroformin addresses this biological interface through complementary skin-conditioning actives. Pro-Vitamin B5 promotes barrier repair, while hyaluronic acid replenishes hydration throughout the tissue, helping maintain a healthier environment for vulnerable sensory nerve endings.

A more complete approach to nerve care

Diabetic peripheral neuropathy is driven by interconnected pathological processes rather than a single mechanism. Metabolic dysfunction, declining skin quality, impaired microvascular support and persistent sensory symptoms evolve together, each reinforcing disease progression.

Nuroformin™ is designed to intervene across these pathways by activating AMPK to improve cellular energy regulation, reinforcing the skin barrier that protects sensory nerve endings, and delivering immediate cooling relief where discomfort is experienced. Together, these complementary actions provide a more comprehensive approach to diabetic neuropathy by addressing both its underlying biology and its day-to-day burden.